Table 4.
Patient attitudes towards AMR mitigation, stratified by level of information
The patient was provided with additional information on the health and economic consequences of AMR (N, %) | Alpha* | |||
No (group A) | Yes (group B) | Total | ||
Antibiotic prescription should be: | ||||
Less restrictive | 63 | 35 | 98 | |
15.75 | 8.75 | 12.25 | ||
Unchanged | 170 | 81 | 251 | |
42.50 | 20.25 | 31.37 | ||
More restrictive | 167 | 284 | 451 | P<0.01 |
41.75 | 71.00 | 56.38 | ||
Total | 400 | 400 | 800 | |
100.00 | 100.00 | 100.00 | ||
Willingness to pay more for health treatment that reduced the risk of AMR | ||||
Yes | 198 | 322 | 280 | |
49.50 | 80.50 | 35.00 | ||
No | 202 | 78 | 520 | P<0.01 |
50.50 | 19.50 | 65.00 | ||
Total | 400 | 400 | 800 | |
100.00 | 100.00 | 100.00 |
Note. Group A—participants not exposed to the intervention (n=400); group B—participants exposed to the intervention (n=400).
*Indicate alpha for statistically significant difference between groups.
AMR, antimicrobial resistance.